{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:06Z","timestamp":1792791546678,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021778","name":"National Agency for the Promotion of Research Technological Development and Innovation","doi-asserted-by":"publisher","award":["PICT 2020-00936"],"award-info":[{"award-number":["PICT 2020-00936"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"National Agency for the Promotion of Research Technological Development and Innovation","doi-asserted-by":"publisher","award":["PICT 2019-01232"],"award-info":[{"award-number":["PICT 2019-01232"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005740","name":"National University of the South","doi-asserted-by":"publisher","award":["PGI 24\/B360"],"award-info":[{"award-number":["PGI 24\/B360"]}],"id":[{"id":"10.13039\/501100005740","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005740","name":"National University of the South","doi-asserted-by":"publisher","award":["PGI 24 \/B298"],"award-info":[{"award-number":["PGI 24 \/B298"]}],"id":[{"id":"10.13039\/501100005740","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005740","name":"National University of the South","doi-asserted-by":"publisher","award":["PGI 24 \/B300"],"award-info":[{"award-number":["PGI 24 \/B300"]}],"id":[{"id":"10.13039\/501100005740","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP11220200102356"],"award-info":[{"award-number":["PIP11220200102356"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111196","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:36:05Z","timestamp":1790350565000},"page":"111196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel allosteric modulation of the human 5-HT3A receptor by the clinically used drugs piperazine and hydroxyzine"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8264-9695","authenticated-orcid":false,"given":"Noelia","family":"Rodriguez Araujo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0258-6140","authenticated-orcid":false,"given":"Jerem\u00edas","family":"Corradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Berg\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0388-6129","authenticated-orcid":false,"given":"Cecilia","family":"Bouzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neuropharm.2026.111196_bib1","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/molecules23123186","article-title":"Natural negative allosteric modulators of 5-HT3 receptors","volume":"23","author":"Al Kury","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111196_bib2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.104.077172","article-title":"Memantine blocks \u03b17* nicotinic acetylcholine receptors more potently than N-Methyl-D-aspartate receptors in rat hippocampal neurons","volume":"312","author":"Aracava","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111196_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2011.01582.x","article-title":"The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine","volume":"165","author":"Baptista-Hon","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111196_bib4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12035-009-8084-x","article-title":"Structural basis of activation of Cys-loop receptors: the extracellular-transmembrane interface as a coupling region","volume":"40","author":"Bartos","year":"2009","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib5","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1038\/s41467-019-11142-8","article-title":"Molecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor","volume":"10","author":"Basak","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41467-018-02997-4","article-title":"Cryo-EM structure of 5-HT3A receptor in its resting conformation","volume":"9","author":"Basak","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111196_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.57870","article-title":"High-resolution structures of multiple 5-HT3AR-setron complexes reveal a novel mechanism of competitive inhibition","volume":"9","author":"Basak","year":"2020","journal-title":"eLife"},{"issue":"31","key":"10.1016\/j.neuropharm.2026.111196_bib8","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1523\/JNEUROSCI.0448-08.2008","article-title":"The interface between extracellular and transmembrane domains of homomeric cys-loop receptors governs open-channel lifetime and rate of desensitization","volume":"28","author":"Bouzat","year":"2008","journal-title":"J. Neurosci."},{"issue":"7002","key":"10.1016\/j.neuropharm.2026.111196_bib9","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature02753","article-title":"Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel","volume":"430","author":"Bouzat","year":"2004","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111196_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0006-3495(86)83539-1","article-title":"A method for the rapid exchange of solutions bathing excised membrane patches","volume":"50","author":"Brett","year":"1986","journal-title":"Biophys. J."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111196_bib11","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cell.2024.01.032","article-title":"Structural mechanisms of \u03b17 nicotinic receptor allosteric modulation and activation","volume":"187","author":"Burke","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.111196_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fphar.2019.00072","article-title":"Cocaine directly inhibits \u03b16-containing nicotinic acetylcholine receptors in human SH-EP1 cells and mouse VTA DA neurons","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bpj.2010.10.046","article-title":"A novel mechanism of modulation of 5-HT3A receptors by hydrocortisone","volume":"100","author":"Corradi","year":"2011","journal-title":"Biophys. J."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111196_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bpj.2009.06.018","article-title":"Single-channel kinetic analysis for activation and desensitization of homomeric 5-HT3A receptors","volume":"97","author":"Corradi","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2026.111196_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111196_bib16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coph.2011.01.010","article-title":"Allosteric modulation of the 5-HT3 receptor","volume":"11","author":"Davies","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"6717","key":"10.1016\/j.neuropharm.2026.111196_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/16941","article-title":"The 5-HT3B subunit is a major determinant of serotonin-receptor function","volume":"397","author":"Davies","year":"1999","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111196_bib19","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/molecules26051211","article-title":"Differential regulation of human serotonin receptor type 3A by chanoclavine and ergonovine","volume":"26","author":"Eom","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/00952990.2016.1210614","article-title":"Palonosetron and hydroxyzine pre-treatment reduces the objective signs of experimentally-induced acute opioid withdrawal in humans: a double-blinded, randomized, placebo-controlled crossover study","volume":"43","author":"Erlendson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.neuropharm.2026.111196_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-3-030-58971-4_11","article-title":"Structure, function and physiology of 5-Hydroxytryptamine receptors subtype 3","volume":"96","author":"Gibbs","year":"2021","journal-title":"Subcell. Biochem."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111196_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/theoncologist.7-5-424","article-title":"5-HT3-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile","volume":"7","author":"Goodin","year":"2002","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111196_bib23","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/molecules27051680","article-title":"The role of serotonin neurotransmission in gastrointestinal tract and pharmacotherapy","volume":"27","author":"Guzel","year":"2022","journal-title":"Molecules"},{"issue":"7514","key":"10.1016\/j.neuropharm.2026.111196_bib24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nature13552","article-title":"X-ray structure of the mouse serotonin 5-HT3 receptor","volume":"512","author":"Hassaine","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111196_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095072","article-title":"Caenorhabditis elegans neuromuscular junction: GABA receptors and ivermectin action","volume":"9","author":"Hernando","year":"2014","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.neuropharm.2026.111196_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111910","article-title":"Tapping into 5-HT3 receptors to modify metabolic and immune responses","volume":"22","author":"Irving","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111196_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.115.230011","article-title":"Noncompetitive inhibition of 5-HT3 receptors by citral, linalool, and eucalyptol revealed by nonlinear mixed-effects modeling","volume":"356","author":"Jarvis","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"7824","key":"10.1016\/j.neuropharm.2026.111196_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2654-5","article-title":"Shared structural mechanisms of general anaesthetics and benzodiazepines","volume":"585","author":"Kim","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111196_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4999\/uhod.10066","article-title":"Effect of hydroxyzine in controlling acute chemotherapy-induced vomiting in children: a randomised trial","volume":"22","author":"Kurucu","year":"2012","journal-title":"Int. J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111196_bib30","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1124\/mol.118.113530","article-title":"Modeling and mutational analysis of the binding mode for the multimodal antidepressant drug vortioxetine to the human 5-HT3A receptor","volume":"94","author":"Ladefoged","year":"2018","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/ijms23010544","article-title":"Hydroxy pentacyclic triterpene acid, kaempferol, inhibits the human 5-hydroxytryptamine type 3A receptor activity","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111196_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pharmthera.2011.02.003","article-title":"Therapeutics of 5-HT3 receptor antagonists: current uses and future directions","volume":"130","author":"MacHu","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"5030","key":"10.1016\/j.neuropharm.2026.111196_bib33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1126\/science.1718042","article-title":"Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel","volume":"254","author":"Maricq","year":"1991","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111196_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1476-5381.1985.tb12929.x","article-title":"\u03b3\u2010Aminobutyric acid\u2010 and piperazine\u2010activated single\u2010channel currents from Ascaris suum body muscle","volume":"84","author":"Martin","year":"1985","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.neuropharm.2026.111196_bib35","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.neuropharm.2026.111196_bib36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.phymed.2018.04.034","article-title":"Yokukansan contains compounds that antagonize the 5-HT3 receptor","volume":"43","author":"Nakamura","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2026.111196_bib37","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3389\/fphar.2020.01274","article-title":"Capsaicin is a negative allosteric modulator of the 5-HT3 receptor","volume":"11","author":"Nebrisi","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111196_bib38","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/bph.12213","article-title":"5-Chloroindole: a potent allosteric modulator of the 5-HT3 receptor","volume":"169","author":"Newman","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111196_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(03)00503-1","article-title":"Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E","volume":"310","author":"Niesler","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2026.111196_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111196_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/138161206775193073","article-title":"Receptor-independent effects of endocannabinoids on ion channels","volume":"12","author":"Oz","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111196_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4196\/kjpp.24.340","article-title":"Atypical antipsychotic drug olanzapine inhibits 5-HT 3 receptor-mediated currents by allosteric and non-competitive mechanisms","volume":"29","author":"Park","year":"2025","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111196_bib43","doi-asserted-by":"crossref","first-page":"RP93174","DOI":"10.7554\/eLife.93174","article-title":"Mapping the molecular motions of 5-HT3 serotonin-gated channel by voltage-clamp fluorometry","volume":"12","author":"Peverini","year":"2024","journal-title":"eLife"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111196_bib44","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.mp.4001490","article-title":"Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner","volume":"9","author":"Rammes","year":"2004","journal-title":"Mol. Psychiatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111196_bib45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/13543776.2016.1189902","article-title":"Piperazine derivatives for therapeutic use: a patent review (2010-present)","volume":"26","author":"Rathi","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111196_bib46","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.bpj.2020.08.029","article-title":"Orthosteric and allosteric activation of human 5-HT3A receptors","volume":"119","author":"Rodriguez Araujo","year":"2020","journal-title":"Biophys. J."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111196_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102356","article-title":"The nematode serotonin-gated chloride channel MOD-1: a novel target for anthelmintic therapy","volume":"298","author":"Rodriguez Araujo","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/molecules29010068","article-title":"Synthetic approaches to piperazine-containing drugs approved by FDA in the period of 2011\u20132023","volume":"29","author":"Romanelli","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib49","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coph.2011.02.005","article-title":"Targeting the 5-HT3 receptor in the treatment of irritable bowel syndrome","volume":"11","author":"Spiller","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111196_bib51","series-title":"StatPearls [Internet]","article-title":"Antiemetics, selective 5-HT3 antagonists","author":"Theriot","year":"2026"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111196_bib52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14728222.11.4.527","article-title":"The 5-HT3 receptor as a therapeutic target","volume":"11","author":"Thompson","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111196_bib53","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/mol.104.000729","article-title":"Alkaloids indolizidine 235B\u2032, quinolizidine 1-epi-2071, and the tricyclic 205B are potent and selective noncompetitive inhibitors of nicotinic acetylcholine receptors","volume":"66","author":"Tsuneki","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111196_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2014.01.072","article-title":"The therapeutic promise of positive allosteric modulation of nicotinic receptors","volume":"727","author":"Uteshev","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111196_bib55","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/mend.12.9.0163","article-title":"Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor","volume":"12","author":"Wetzel","year":"1998","journal-title":"Mol. Endocrinol."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111196_bib56","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bcp.2011.05.001","article-title":"Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations","volume":"82","author":"Williams","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111196_bib57","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41467-021-21016-7","article-title":"Asymmetric opening of the homopentameric 5-HT3A serotonin receptor in lipid bilayers","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:54:18Z","timestamp":1792788858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":57,"alternative-id":["S0028390826003710"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111196","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel allosteric modulation of the human 5-HT3A receptor by the clinically used drugs piperazine and hydroxyzine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111196"}}